Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2002-07-08
2008-11-18
Campell, Bruce (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Reexamination Certificate
active
07452963
ABSTRACT:
The present invention provides a new class of peptides related to rapid replication and their use in diagnosing, preventing and treating disease.
REFERENCES:
patent: 5104854 (1992-04-01), Schlesinger et al.
patent: 5231167 (1993-07-01), Zanetti et al.
patent: 5280113 (1994-01-01), Rademacher
patent: 5679352 (1997-10-01), Chong
patent: 5866690 (1999-02-01), Bogoch
patent: 6023659 (2000-02-01), Seilhamer
patent: 6070126 (2000-05-01), Kokolus
patent: 6242578 (2001-06-01), Bogoch
patent: 6256647 (2001-07-01), Toh
patent: 6638505 (2003-10-01), Bogoch
patent: 2005/0271676 (2005-12-01), Sette
patent: 0108564 (1984-05-01), None
patent: 98MI0874 (1999-10-01), None
patent: 96/32106 (1996-10-01), None
patent: WO 00/18351 (2000-04-01), None
patent: 0104135 (2001-01-01), None
patent: 02085093 (2002-10-01), None
patent: 03005880 (2003-01-01), None
Rodman et al. J. Exp. Med. 175: 1247-1253.
Weber et al. Virology 1988, vol. 164, pp. 30-38.
Gelder, CM et al., “Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection,” J. Virol., 1995, vol. 69, No. 12, pp. 7497-7506.
Pannifer, et al. “Crystal structure of the anthrax lethal factor,”Nature, vol. 414, pp. 229-233, (Nov. 2001).
Zhao, et al. “Neutralizing monoclonal antibody against Anthrax lethal factor inhibits intoxication in a mouse model,”Human Antibodies, vol. 12, pp. 129-135, (2003).
Brown, L. R. et al., “Recognition of the influenza hemagglutinin by Class II MHC-restricted T lymphocytes and antibodies,”Journal of Immunology, Oct. 15, 1991, pp. 2677-2684, vol. 147, No. 8, American Association of Immunologists, USA, XP002371257, ISSN: 0022-1767.
Atassi, M. Z. et al., “A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: Antibody and T cell activity to several influenza hemagglutinin synthetic sites,”Immunological Communications, 1984, pp. 539-551, vol. 13, No. 6, Marcel Dekker, Inc., XP009062995, ISSN: 0090-0877.
Carr, C. M. et al. “A spring-loaded mechanism for the conformational change of influenza hemagglutinin,”Cell, May 21, 1993, pp. 823-832, vol. 73, Cell Press, XP002059698; ISSN: 0092-8674.
Ben-Yedidia, T. et al., “Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection,”International Immunology, 1999, pp. 1043-1051, XP000914818, ISSN: 0953-8178.
Schenk, S. et al., “Four recombinant isoforms ofCor a1, the major allergen of hazel pollen, show different reactivities with allergen-specific T-lymphocyte clones,”European Journal of Biochemistry, 1994, pp. 717-722, vol. 224, XP002371408, ISSN: 0014-2956.
Orlando, C. et al., “A monoclonal antibody directed against the catalytic site ofBacillus anthracisadenylyl cyclase identifies a novel mammalian brain catalytic subunit,”Biochemistry, 1992, pp. 3215-3222, vol. 31, American Chemical Society, XP002371438, ISSN: 0006-2960.
Supplementary Partial European Search Report 03721445.9, Dec. 12, 2006, EPO, International Searching Authority, Munich, DE.
PCT International Search Report, PCT/US2002/09240, Jan. 14, 2004, USPTO, International Searching Authority, Washington DC.
PCT International Preliminary Examination Report, PCT/US2002/09240, Feb. 5, 2004, USPTO, International Preliminary Examination Authority, Alexandria, VA, USA.
PCT International Search Report, PCT/US2002/21494, May 30, 2003, USPTO, International Searching Authority, Washington DC.
NCBI Accession No. NP 740460, residues 201-210.
PCT International Search Report, PCT/US2003/08990, Dec. 7, 2005, International Searching Authority, USPTO, Alexandria, VA, USA.
PCT International Search Report, PCT/US2004/017936, Apr. 28, 2005, EPO, International Searching Authority, Rijswijk, NL.
PCT Written Opinion of the International Searching Authority, PCT/US2004/017936, Apr. 7, 2005, EPO, International Searching Authority, Munich, DE.
PCT International Preliminary Report on Patentability, PCT/US2004/017936, Apr. 13, 2007, USPTO, International Preliminary Examining Authority, Alexandria, VA, USA.
PCT International Preliminary Report on Patentability, PCT/US2005/014443, Nov. 1, 2006, WIPO, International Bureau of WIPO, Geneva, Switzerland.
PCT Written Opinion of the International Searching Authority, PCT/US2005/014443, Apr. 12, 2006, EPO, International Searching Authority, Munich, DE.
Bogoch, S. et al., “A Checklist for Suitability of Biomarkers as Surrogate Endpoints in Chemoprevention of Breast Cancer,” Journal of Cellular Biochemistry, Supplement, Boston, US, vol. 19, pp. 173-185, XP009046492, ISSN: 0733-1959, 1994.
Bucher, D. et al., “M protein (M1) of influenza virus antigenic analysis and intracellular localization with monoclonal antibodies”, J Virol. Sep. 1989; 63(9): pp. 3622-3633.
Chambers, T.M. et al., “Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus,” Database NCBI on STN, Accession No. HMIVT2, Virology, pp. 180-188, abstract, 1989, 172(1).
SHI, Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine, PNAS vol. 96, No. 4, pp. 1615-1620.
Tanaka, T. et al., “Efficient Generation of Antibodies to Oncoproteins by using Synthetic Peptide Antigens.” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, D.C., US, v. 82, No. 10, p. 3400-3404, tables 1, Peptide 21, XP000113798, ISSN: 0027-8424, May 1, 1985.
3Motif—Search Instructions, 3motif in three Dimensions, article titles “Submitting a protein sequence”: http://brutlag.sanford.edu/3motif/search—instr.html).
NCBI accession # gi 75059 Jul. 16, 1999.
NCBI Listing JQ0032, residues 74-82, May 11, 2000.
NCBI Query Tutorial “Introduction” (http:/
cbi.nim.nih.gov/Education/BLASTinfo/query—tutorial.html).
NCBI Query Tutorial “Introduction to a BLAST Query” (http://www.ncbi.nim.nih.gov/Education/BLASTinfo/tut1.html).
NCBI Query Tutorial “Setting up a BLAST Search” (http:///www.ncbi.nim.nih.gov/Education/BLASTinfo/Blast—setup.html).
NCBI Blast Searching, Gene Gateway—Exploring Genes and Genetic Disorders, “Sequence similarity searching using NCBI Blast” (http:www.ORNL.gov/sci/techresources/Himan—Genome/chromosome/blast.shtml).
Abrams M. B. et al., “Early Detection and Monitoring of cancer with the Anti-Malignin Antibody Test,” Cancer detection and Prevention, XX, XX, vol. 18, No. 1, 1994, pp. 65-78, XP000673180, ISSN:0361-090X.
Bogoch et al., “Aglyco Pathology of Viral Receptors in Dementias,” Annals of the New York Academy of Sciences, New York Academy of Sciences, New York Academy of Sciences, New York, NY, US, vol. 757, 1995, pp.413-417, XP008003395, ISSN:0077-8923.
Keppeler et al., “Elongation of thr N-acyl side chain of sialic acid in MDCK II cells inhibits influenza A virus infection,” abstract Biochemical amd Biophysical Research Communications, Dec. 18, 1998, vol. 253, No. 2. Database Medline on STN, National Library of Medicine, (Bethesda, MD, USA), No. 99097253.
Kornblith P. L. et al., “Growth-inhibitory effect of diphenylhydantoin on murine astrocytomas,” Medline, XP002199627.
Margalit et al., “Prediction of Immunodomaint Helper T Cell Antigenic Sites From the Primary Sequence,” Jour. Of Immunology, vol. 138, 2213-2229, Apr. 1, 1987.
Seal et al., “Elevation of Serum Protein-Bound Carbohydrates and Haptoglobin in Schrzophrenia,” Clincal Chemistry; Oct. 1996, vol. 12, No. 10, pp. 709-716.
PCT International Search Report, PCT/US2005/014443, Oct. 21, 2006, EPO, International Searching Authority, Munich, DE.
EP Supplementary Search 99944002, Apr. 20, 2004.
Bogoch et al., “Rapid replication and Replikintm structures: basis of the AMASRTest and CAVAXR,” Cancer Detection and Prevention Online, Feb. 9, 2002,
Bogoch Elenore S.
Bogoch Samuel
Campell Bruce
Hill Myron G.
Kenyon & Kenyon LLP
LandOfFree
Replikin peptides and antibodies therefore does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replikin peptides and antibodies therefore, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replikin peptides and antibodies therefore will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4040209